We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
Cap. Flow
+$1B
Cap. Flow %
7.59%
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$120M
2
GL icon
Globe Life
GL
+$115M
3
MPT
Medical Properties Trust
MPT
+$91.5M
4
ACGL icon
Arch Capital
ACGL
+$69.2M
5
AMZN icon
Amazon
AMZN
+$45.6M

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$138M
2
GSK icon
GSK
GSK
+$98.7M
3
CCK icon
Crown Holdings
CCK
+$92.3M
4
AWK icon
American Water Works
AWK
+$54M
5
SEDG icon
SolarEdge
SEDG
+$45.7M

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Financials 15.05%
3 Healthcare 13.07%
4 Consumer Discretionary 9.61%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SFL icon
1726
SFL Corp
SFL
$1.58B
$43K ﹤0.01%
+7,000
New +$48.5K
SGOL icon
1727
abrdn Physical Gold Shares ETF
SGOL
$7.49B
$43K ﹤0.01%
2,405
+2,025
+533% +$36.5K
TXRH icon
1728
Texas Roadhouse
TXRH
$13.6B
$43K ﹤0.01%
555
+71
+15% +$5.29K
MYJ
1729
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
$43K ﹤0.01%
3,024
– –
NAV
1730
DELISTED
Navistar International
NAV
$43K ﹤0.01%
1,000
– –
ALLK
1731
DELISTED
Allakos
ALLK
$42K ﹤0.01%
300
– –
CAKE icon
1732
Cheesecake Factory
CAKE
$5.53B
$42K ﹤0.01%
1,134
-110
-9% -$3.77K
HUBB icon
1733
Hubbell
HUBB
$26.7B
$42K ﹤0.01%
277
+23
+9% +$3.53K
TXMD icon
1734
TherapeuticsMD
TXMD
$24M
$42K ﹤0.01%
700
– –
VITL icon
1735
Vital Farms
VITL
$483M
$42K ﹤0.01%
+1,660
New +$52.5K
ARNA
1736
DELISTED
Arena Pharmaceuticals Inc
ARNA
$42K ﹤0.01%
550
-100
-15% -$7.5K
BTRSW
1737
DELISTED
BTRS Holdings Inc. Warrants
BTRSW
$42K ﹤0.01%
+10,000
New +$27.4K
BTAI icon
1738
BioXcel Therapeutics
BTAI
$28.7M
$41K ﹤0.01%
56
– –
EXEL icon
1739
Exelixis
EXEL
$13.1B
$41K ﹤0.01%
2,058
+1,000
+95% +$20.9K
FIBK icon
1740
First Interstate BancSystem
FIBK
$3.56B
$41K ﹤0.01%
1,029
+29
+3% +$1.1K
FNF icon
1741
Fidelity National Financial
FNF
$12.9B
$41K ﹤0.01%
1,123
+684
+156% +$23.1K
INSG icon
1742
Inseego
INSG
$87.7M
$41K ﹤0.01%
268
-500
-65% -$55.2K
LILAK icon
1743
Liberty Latin America Class C
LILAK
$1.65B
$41K ﹤0.01%
4,133
+1,091
+36% +$10.8K
GCV
1744
Gabelli Convertible and Income Securities Fund
GCV
$94.9M
$40K ﹤0.01%
6,445
+5,445
+545% +$31.3K
GSBD icon
1745
Goldman Sachs BDC
GSBD
$1.1B
$40K ﹤0.01%
2,110
+61
+3% +$1.05K
SCHB icon
1746
Schwab US Broad Market ETF
SCHB
$44.8B
$40K ﹤0.01%
2,664
-36
-1% -$513
SPYM
1747
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
$40K ﹤0.01%
917
– –
UDR icon
1748
UDR
UDR
$12.1B
$40K ﹤0.01%
1,070
+460
+75% +$16.8K
PSXP
1749
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$40K ﹤0.01%
1,533
-230
-13% -$5.99K
GVIP icon
1750
Goldman Sachs Hedge Industry VIP ETF
GVIP
$573M
$39K ﹤0.01%
428
-16
-4% -$1.34K
68 69
70
71 72

Similar funds

Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Rockefeller Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.

  • Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
  • Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
  • Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
  • Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
  • Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
  • Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
  • Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.